Volume : 09, Issue : 06, June – 2022
Title:
17.A SCHEMATIC APPROACH OF EMULSIFYING AGENT AND PERMEATION ENHANCER IN CREAM.
Authors :
Satish Yadav*, Sailesh kumar Ghatuary, Satkar Prasad, Monika Parmar
Abstract :
Topical route of application has a great potential as an effective and safe way to administer drug for its antifungal in effect. The concentration of surfactant and permeation enhancer significantly affects the critical parameters of cream formulation like flux, cumulative amount released at 12 hours and Enhancement ratio. In vitro permeation study across rat epidermal membrane showed that menthol enhanced the transdermal absorption of drug from cream formulation. The topical cream formulation developed in this study holds the promise for the further in vivo studies.
The aim of the present work under investigation is to check the effects of emulsifying agents(Cremophore RH40, Tween 60) and permeation enhancers (l-Menthol) on cream. Developing a formulation that is safe and can deliver the drug locally in an effective concentration for its effect . The development of topical antifungal drug delivery systems designed to have localised effects appears to be very advisable and beneficial over conventional routes of drug administration. However, due to the relative impermeability of the stratum corneum, which provides the principal resistance to percutaneous absorption, extensive studies are generally necessary in order to optimize both the release of the drug from the topical vehicle and skin permeation Further, A topical formulation must be aesthetically pleasing, in addition to being both physically and chemically stable, this require numerous excipients. Emulsifying agents and permeation enhancers have major influence on these properties, hence they play an important role.
Key words: of emulsifying agents, Permeation enhancers, stratum corneum, Antifungal , Topical cream
Cite This Article:
Please cite this article in press Satish Yadav et al, A Schematic Approach Of Emulsifying Agent And Permeation Enhancer In Cream., Indo Am. J. P. Sci, 2022; 09(6).,
Number of Downloads : 10
References:
1. Agyralides, G.G., Dallas, P.P., Rekkas, D.M., 2004.Development and in vitro evaluation of furosemide transdermal formulations using experimental design techniques. Int. J. Pharm. 281, 35–43.
2. Asmussen, B. Transdermal therapeutic systems: actual state and future developments. Methods Find. Exp. Clin. Pharmacol. 1991; 13: pp. 343–351
3. Giannakou, S.A., Dallas, P.P., Rekkas, D.M., Choulis, N.H., 1995. Development and in vitro evaluation of nitrendipine transdermal formulations using experimental design techniques. Int. J. Pharm. 125, 7–15.
4. Govil, S.K. Transdermal Drug Delivery Devices, In Tyle P, ed Drug delivery devices, Fundamentals and Applications, New York , Marcel Dekker, 1988 pp. 386-419.
5. Hadgraft, J; Williams, D.G.; Allan, g.; in Pharmaceutical Skin Penetration Enhancement Walters, K.A., Hadgraft, J. Eds.; Marcel Dekker, New York. 1993; pp. 175-197.
6. Hamed, E., Sakr, A., 2001. Application of multiple response optimization technique to extended release formulations design. J. Control. Rel. 73, 329–338.
7. Hsieh, D.S. Drug Permeation Enhancement, Marcel Dekker, New York, 1994 pp.323-343.
8. Kydonieus, A.F. Fundamentals of transdermal drug delivery. In: Kydonieus, A.F., Berner, B. (Eds.), Transdermal Delivery of Drugs, CRC Press, Boca Raton, FL, 1987; pp. 4–6.
9. Li, W., Nadig, D., Rasmussen, H.T., Patel, K., Shah, T., 2005. Sample preparation optimization for assay of active pharmaceutical ingredients in a transdermal drug delivery system using experimental designs J. Pharm. Biomed. Anal. 37, 493–498.
10. Shah, V.P., Elkins, J.S., Williams, R.L., 1999. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products. Pharm. Dev. Tech. 4,377– 385.
11. Takayama, K., Nagai, T., 1989. Novel computer optimization methodology for pharmaceutical formulations investigated by using sustained-release granules of indomethacin. Chem. Pharm. Bull. 37, 160–167.
12. Walters, K.A. Penetration enhancers and their use in transdermal therapeutic systems. In: Hadgraft, J., Guy, R.H. (Eds.), Transdermal Drug Delivery, Marcel Dekker, New York, 1989; pp. 197–233.